Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-15

Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety and efficacy of an olanzapine titration schedule in patients with schizophrenia; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Schizophrenia | Phase 2 | Status: RECRUITING